Festival of Biologics USA

Call for Papers

The Festival of Biologics is the meeting place for the life science community to bridge the gap between academia and industry.

With three events in one, we encourage conversation so you can inspire change, champion innovation, and address complex challenges that the biologics industry is facing. Together, we're improving patient health.

Mission: To bring together senior biologics professionals across the value chain to showcase their research, collaborate on challenges, forge new connections and ultimately advance the industry to improve patient health. 

Save 15% off your congress pass with the code Evvnt15.

Key Themes:

- AI and Machine Learning in Oncology and Biomarkers 

- Antibodies for immunotherapy 

- Bispecifics discovery/development 

- Building a sustainable biosimilars industry 

- Cancer Vaccines 

- Cell Therapy 

- Checkpoint Inhibitors 

- Clinical Trials

- CMC, developability and manufacturability 

- Commercialization and Market Access 

- Oncolytic Viruses 

- Precision Immunotherapy 

- Protein engineering 

- Building a sustainable biosimilars industry 

Time: 09:00 to 18:00

Speakers: Erica Ollmann Saphire, Professor, La Jolla Institute for Immunology, Bruce Keyt, CSO, IGM Biosciences, Philip Tagari, VP. Therapeutic Discovery, Amgen, David Dornan, Senior Vice President of Research, Bolt Biotherapeutics, Joan Shen, CEO, I-Mab Biopharma, Andrew Allen, President and Chief Executive Officer, Gritstone Oncology, Bob Valamehr, Vice President of Cancer Immunotherapy, Fate Therapeutics, Ira Mellman, Vice President, Cancer Immunology, Genentech, William Chou, Vice President, Global Commercial Disease Leader, Novartis, Roy Baynes, Senior Vice President and Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme, Christine Simmon, Executive Director/Senior Vice President, Policy and Strategic Alliances, Biosimilars Council/Association of Accessible Medicines, John O'Brien, Former Senior Adviser to the Secretary for Drug Pricing Reform, U.S. Department of Health and Human Services, Noelle Sunstrom, CEO and Founder, NeuClone, Pam Traxel, Senior Vice President, Alliance Development and Philanthropy, American Cancer Society Cancer Action Network , Scott Liu, CEO, Shanghai Henlius